ACHV Achieve Life Sciences, Inc.
Healthcare$4.56-2.77%ClosedMarket Cap: $243.6M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
23.45
P/S
0.00
EV/EBITDA
-4.62
DCF Value
$0.12
FCF Yield
-18.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-193.5%
ROA
-157.0%
ROIC
-195.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-10.5M | $-10.2M | $— | — |
| Q4 null | $0.00 | NaN% | $-14.7M | $-14.7M | $— | — |
| FY null | $0.00 | -Infinity% | $-54.9M | $-54.6M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-14.7M | $-14.4M | $— | — |
| Q2 null | $0.00 | NaN% | $-12.6M | $-12.7M | $— | — |
| Q1 null | $0.00 | NaN% | $-12.9M | $-12.8M | $— | — |
| Q4 null | $0.00 | NaN% | $-12.2M | $-12.4M | $— | — |
| FY null | $0.00 | -Infinity% | $-39.1M | $-39.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-12.5M | $-12.5M | $— | — |
| Q2 null | $0.00 | NaN% | $-8.4M | $-8.5M | $— | — |
| Q1 null | $0.00 | NaN% | $-6.0M | $-6.5M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-4.4M | $-5.5M | $-0.26 | — |